How 'Fat Studies' endangers public health

In Focus delivers deeper coverage of the political, cultural, and ideological issues shaping America. Published daily by senior writers and experts, these in-depth pieces go beyond the headlines to give readers the full picture. You can find our full list of In Focus pieces here.

The Wall Street Journal reported in August that fat activists, people who advocate to eliminate the social stigmas faced by fat people, are attacking Ozempic, the anti-obesity drug, for fueling the perception that fatness is a disorder instead of a harmless difference.